Results 331 to 340 of about 304,634 (351)

Cyclophosphamide

Reactions Weekly, 1994
openaire   +1 more source

Paclitaxel After Doxorubicin Plus Cyclophosphamide As Adjuvant Chemotherapy for Node-Positive Breast Cancer: Results From NSABP B-28

Journal of Clinical Oncology, 2005
Eleftherios P Mamounas, Greg Yothers
exaly  

Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin–cyclophosphamide chemotherapy

Cancer Immunology, Immunotherapy, 2008
C Marcela Diaz-Montero, Mohamed Labib Salem, Elizabeth Garrett-Mayer   +2 more
exaly  

Cyclophosphamide

Reactions Weekly, 2010
openaire   +1 more source

Cyclophosphamide

Reactions Weekly, 1990
openaire   +1 more source

Immunochemotherapy With Rituximab and Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Significantly Improves Response and Time to Treatment Failure, But Not Long-Term Outcome in Patients With Previously Untreated Mantle Cell Lymphoma: Results of a Prospective Randomized Trial of the German Low Grade Lymphoma Study Group (GLSG)

Journal of Clinical Oncology, 2005
Eva Hoster, Bernd Metzner
exaly  

Cyclophosphamide

2011
openaire   +1 more source

Cyclophosphamide

Reactions Weekly, 1993
openaire   +1 more source

Metronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients

Cancer Immunology, Immunotherapy, 2007
Francois Ghiringhelli, Cedric Menard, Sylvain Ladoire   +2 more
exaly  

Cyclophosphamide

2006
openaire   +1 more source